Evidence map›Paper›PMID 33902483›Full record

Observational studyBMC pregnancy and childbirth2021

SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during the first wave.

Itzíar Carrasco, Mar Muñoz-Chapuli, Sara Vigil-Vázquez, David Aguilera-Alonso, Concepción Hernández, César Sánchez-Sánchez, Cristina Oliver, Mónica Riaza, Marta Pareja, Olga Sanz and 8 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC pregnancy and childbirth, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 1 country.

Itzíar CarrascoPaediatric Infectious Disease Unit, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. itziiaarcg@gmail.com.
Mar Muñoz-ChapuliDepartment of Obstetrics and Gynecology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Sara Vigil-VázquezDepartment of Neonatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
David Aguilera-AlonsoPaediatric Infectious Disease Unit, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Concepción HernándezDepartment of Obstetrics and Gynecology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
César Sánchez-SánchezDepartment of Paediatric Gastroenterology Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Cristina OliverDepartment of Obstetrics and Gynecology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Mónica RiazaDepartment of Paediatrics, Hospital Universitario HM Montepríncipe, Madrid, Spain.
Marta ParejaDepartment of Paediatrics, Hospital General de Albace, Castilla La Mancha, Spain.
Olga SanzDepartment of Obstetrics and Gynecology, Complejo Hospitalario de Navarra, Navarra, Spain.
Beatriz Pérez-SeoaneDepartment of Neonatology, Hospital Universitario Infanta Sofía, Madrid, Spain.
Juan LópezDepartment of Paediatrics, Hospital Universitario Infanta Leonor, Madrid, Spain.
Elena MárquezDepartment of Paediatrics, Hospital San Pedro de Alcántara, Cáceres, Spain.
Sara Domínguez-RodríguezPaediatric Infectious Diseases Unit, Fundación para la Investigación Biomédica del Hospital 12 de Octubre, Madrid, Spain.
Alicia Hernanz-LoboPaediatric Infectious Disease Unit, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Juan Antonio De León-LuisFacultad de Medicina Universidad Complutense de Madrid, Madrid, Spain.
Manuel Sánchez-LunaFacultad de Medicina Universidad Complutense de Madrid, Madrid, Spain.
María Luisa NavarroPaediatric Infectious Disease Unit, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Hospital General Universitario Gregorio Marañón · ESUniversidad Complutense de Madrid · ESComplejo Hospitalario de Navarra · ESHospital General Universitario de Albacete · ESHospital San Pedro de Alcántara · ESHospital Universitario HM Madrid · ESHospital Universitario Infanta Leonor · ESHospital Universitario Infanta Sofía · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKnowledge about SARS-CoV-2 infection in pregnancy and newborns is scarce. The objective of this study is to analyse clinical and epidemiological characteristics of a cohort of women infected with SARS-CoV-2 during pregnancy and their newborns exposed to SARS-CoV-2 during gestation.

methodsMulticentric observational study of Spanish hospitals from the GESNEO-COVD cohort, participants in RECLIP (Spanish Network of Paediatric Clinical Assays). Women with confirmed SARS-CoV-2 infection by PCR and/or serology during pregnancy, diagnosed and delivering during the period 15/03/2020-31/07/2020 were included. Epidemiological, clinical, and analytical data was collected.

resultsA total of 105 pregnant women with a median of 34.1 years old (IQR: 28.8-37.1) and 107 newborns were included. Globally, almost 65% of pregnant women had some COVID-19 symptoms and more than 43% were treated for SARS-COV-2. Overall, 30.8% of pregnant women had pneumonia and 5 (4.8%) women were admitted to the intensive care unit needing invasive mechanical ventilation. There was a rate of 36.2% of caesarean sections, which was associated with pneumonia during pregnancy (OR: 4.203, CI 95%: 1.473-11.995) and lower gestational age at delivery (OR: 0.724, CI 95%: 0.578-0.906). The prevalence of preterm birth was 20.6% and prematurity was associated with pneumonia during gestation (OR: 6.970, CI95%: 2.340-22.750) and having a positive SARS-CoV-2 PCR at delivery (OR: 6.520, CI95%: 1.840-31.790). All nasopharyngeal PCR in newborns were negative at birth and one positivized at 15 days of life. Two newborns died, one due to causes related to prematurity and another of unexpected sudden death during early skin-to-skin contact after delivery.

conclusionsAlthough vertical transmission has not been reported in this cohort, the prognosis of newborns could be worsened by SARS-CoV-2 infection during pregnancy as COVID-19 pneumonia increased the risk of caesarean section deliveries and preterm births.

Indexed as

AdultAnti-Bacterial AgentsAntiviral AgentsCarrier StateCesarean SectionCohort StudiesComorbidityCoughCOVID-19COVID-19 Drug TreatmentCOVID-19 Nucleic Acid TestingDiabetes, GestationalDyspneaFemaleFeverGestational AgeAnti-Bacterial AgentsAntiviral AgentsImmunologic FactorsCaesarean sectionCOVID-19MorbidityMortalityNewbornPneumoniaPregnancyPreterm birthSARS-CoV-2

Identifiers

PMID33902483
PMCPMC8072086
OpenAlexW3157216344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.